Literature DB >> 27206890

Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.

Francesca Notturno1, Norito Kokubun2, Yukari Sekiguki3, Takahide Nagashima2, Angelo De Lauretis4, Nobuhiro Yuki5, Satoshi Kuwabara3, Antonino Uncini6.   

Abstract

Guillain-Barré syndrome (GBS) is considered a monophasic disorder yet recurrences occur in up to 6% of patients. We retrospectively studied an Italian-Japanese population of 236 GBS and 73 Miller Fisher syndrome (MFS) patients and searched for factors which may be associated with recurrence. A recurrent patient was defined as having at least two episodes that fulfilled the diagnostic criteria for GBS and MFS with an identifiable recovery after each episode and a minimum of 2months between episodes. Preceding Campylobacter jejuni (C. jejuni) infection and antiganglioside antibodies were also assessed. Seven (3%) recurrent GBS and one (1.4%) recurrent MFS patients were identified. In the individual patient the clinical features during episodes were usually similar varying in severity whereas the preceding infection differed. None of the patients had GBS in one episode and MFS in the recurrence or vice versa. Recurrent GBS patients, compared with monophasic GBS, did not have preceding diarrhea at the first episode and considering the electrophysiological subtypes, acute inflammatory demyelinating polyneuropathies recurred more frequently than axonal GBS (6.5% vs 0.9%, p=0.04). In conclusion in a GBS population with a balanced number of demyelinating and axonal subtypes less frequent diarrhea and demyelination at electrophysiology were associated with recurrence.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Acute inflammatory demyelinating polyneuropathy; Axonal Guillain-Barré syndrome; Guillain-Barré syndrome; Miller Fisher syndrome; Recurrence

Mesh:

Substances:

Year:  2016        PMID: 27206890     DOI: 10.1016/j.jns.2016.02.053

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

Review 1.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

2.  An Adult Case of Recurrent Guillain-Barré Syndrome with Anti-galactocerebroside Antibodies.

Authors:  Hisashi Takahashi; Tadashi Kimura; Natsuko Yuki; Akira Yoshioka
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.